Cargando…
The Role of Peroxisome Proliferator-Activated Receptor Gamma and Atherosclerosis: Post-translational Modification and Selective Modulators
Atherosclerosis is the hallmark of cardiovascular disease (CVD) which is a leading cause of death in type 2 diabetes patients, and glycemic control is not beneficial in reducing the potential risk of CVD. Clinically, it was shown that Thiazolidinediones (TZDs), a class of peroxisome proliferator-act...
Autores principales: | Yin, Liqin, Wang, Lihui, Shi, Zunhan, Ji, Xiaohui, Liu, Longhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924581/ https://www.ncbi.nlm.nih.gov/pubmed/35309069 http://dx.doi.org/10.3389/fphys.2022.826811 |
Ejemplares similares
-
The Potential Roles of Post-Translational Modifications of PPARγ in Treating Diabetes
por: Ji, Xiaohui, et al.
Publicado: (2022) -
Modulation of the Transcriptional Activity of Peroxisome Proliferator-Activated Receptor Gamma by Protein-Protein Interactions and Post-Translational Modifications
por: Kim, Tae-Hyun, et al.
Publicado: (2013) -
Sirtuin Oxidative Post-translational Modifications
por: Kalous, Kelsey S., et al.
Publicado: (2021) -
Kinetic characterization of selective peroxisome-proliferator-activated receptor gamma modulators in vitro
por: Knape, T, et al.
Publicado: (2012) -
Multilevel Regulation of Peroxisomal Proteome by Post-Translational Modifications
por: Sandalio, Luisa M., et al.
Publicado: (2019)